SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-18-006012
Filing Date
2018-09-12
Accepted
2018-09-12 15:19:51
Documents
1
Period of Report
2018-09-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-42916.html 3  
1 PRIMARY DOCUMENT marketforms-42916.xml 3 1706
  Complete submission text file 0001214659-18-006012.txt   3075
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PENNZOIL PLACE 700 MILAM, SUITE 1300 HOUSTON TX 77002
Business Address
McManigle Mark Drew (Reporting) CIK: 0001751524 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34637 | Film No.: 181066740